Business
Anti-inflammatory drug may shorten COVID-19 recovery time – Sydney Morning Herald
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.
Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalised COVID-19 patients.
It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised COVID-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.
Figuring out how to best use t…
-
General22 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
Business22 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General21 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General20 hours agoCool weather sets cherry crops ‘weeks’ behind schedule in lead-up to Christmas